Healthcare - Biotechnology - NASDAQ - US
$ 28.09
-5.61 %
$ 1.96 B
Market Cap
-7.43
P/E
BALANCE SHEET
580 M
ASSETS
45 M
LIABILITIES
535 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Akero Therapeutics, Inc.
| Current Assets | 560 M |
| Cash & Short-Term Investments | 550 M |
| Receivables | 0 |
| Other Current Assets | 9.95 M |
| Non-Current Assets | 20.3 M |
| Long-Term Investments | 19.3 M |
| PP&E | 1.03 M |
| Other Non-Current Assets | 0 |
| Current Liabilities | 19.1 M |
| Accounts Payable | 7.04 M |
| Short-Term Debt | 522 K |
| Other Current Liabilities | 11.6 M |
| Non-Current Liabilities | 25.8 M |
| Long-Term Debt | 25.8 M |
| Other Non-Current Liabilities | 54 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 234.2 | 249.8 | 150.5 | 187.2 | 136.4 | 76.0 | 0.6 |
| Short Term Investments | 315.8 | 101.7 | 37.8 | 81.1 | 71.6 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 10.0 | 7.4 | 10.6 | 5.9 | 3.3 | 2.3 | 80 K |
| Total Current Assets | 560.0 | 355.2 | 193.6 | 271.3 | 138.0 | 77.1 | 0.6 |
| PP&E | 1.0 | 1.3 | 1.5 | 1.8 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 19.3 | 0 | 0 | 40 K | 40 K | 20 K | 20 K |
| Other Long Term Assets | 0 | 0.1 | 0.4 | 0.2 | 29 K | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 580.3 | 356.6 | 195.5 | 273.3 | 138.1 | 77.2 | 0.7 |
| LIABILITIES | |||||||
| Accounts Payable | 7.0 | 8.0 | 6.7 | 3.4 | 0.9 | 1.4 | 60 K |
| Short Term Debt | 0.5 | 0.3 | 0.2 | 0.3 | 85 K | 0 | 0 |
| Other Current Liabilities | 11.6 | 10.8 | 18.2 | 9.4 | 8.3 | 1.0 | 0.2 |
| Total Current Liabilities | 19.1 | 19.1 | 25.1 | 13.1 | 9.4 | 2.3 | 0.2 |
| Long Term Debt | 25.8 | 10.6 | 2.6 | 3.0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 54 K | 0.3 | (1.3) | (1.5) | 23 K | 124.7 | 5.0 |
| Total Liabilities | 45.0 | 30.0 | 26.4 | 14.6 | 9.4 | 127.1 | 5.2 |
| EQUITY | |||||||
| Common Stock | 6 K | 5 K | 4 K | 4 K | 3 K | 0 | 0 |
| Retained Earnings | (574.1) | (422.3) | (310.3) | (209.5) | (130.3) | (86.6) | (4.6) |
| Other Accumulative Comprehensive Income/Loss | 0.3 | 37 K | 27 K | 3 K | 6 K | 0 | 0 |
| Total Equity | 535.3 | 326.6 | 169.1 | 258.7 | 128.7 | (49.9) | (4.6) |
| Total Liabilities and Equity | 580.3 | 356.6 | 195.5 | 273.3 | 138.1 | 77.2 | 0.7 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 52.6 | 39.0 | 34.8 | 31.5 | 15.1 | 21.2 | 28.6 |